Pilot Testing of a Mobile Phone App-based Intervention for Parents of Children With Autism Spectrum Disorder (ASD)

Sponsor
Chinese University of Hong Kong (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05927207
Collaborator
(none)
40
2
6

Study Details

Study Description

Brief Summary

The objective of this study is to conduct a pilot randomised controlled trial (RCT) evaluating the feasibility, acceptability, and preliminary efficacy of a 6-week mobile app-based intervention in empowering and supporting Chinese parents of autism spectrum disorder (ASD) children through knowledge and skills transfer and mindfulness training. The investigators hypothesise that the app will be feasible and acceptable, and that there will be a greater reduction in parental stress and mood symptoms, and improvement of mindfulness attitude and parenting competence in parents with ASD children after the 6-week app-based intervention than the waitlist controls.

Condition or Disease Intervention/Treatment Phase
  • Other: TRIP
N/A

Detailed Description

Parents of autism spectrum disorder (ASD) children are often stressed about challenges in raising their children with multifaceted needs, and their stress could undermine the child's development. With the ever-increasing demand in clinical services and disruptions by the coronavirus pandemic (COVID-19), the aim of the study is to investigate the clinical efficacy of a mobile app-based intervention in reducing stress and mood symptoms, and enhancing mindfulness and competence in parents of children with ASD. The 6-week mobile app-based intervention programme, TRIP, is a structured course of mindfulness training, and knowledge and skills transfer of parenting ASD children with specific content personalised to the participant's needs, which was developed as an accessible and scalable primary-level care platform to improve the well-being of parents.

In this study, a pilot randomized waitlist-controlled trial will be conducted. 40 parents of ASD children who are ≤12 years of age and either 1. waiting for, or 2. actively receiving treatment from a regional children psychiatric specialist clinic will be recruited. Parents will be randomized into an immediate intervention arm and a waitlist arm. Feasibility, acceptability, as well as preliminary efficacy of the app will be investigated. Parental stress level, mood symptoms, competence, and level of mindfulness will be measured before, immediately after, and 2 months after the intervention with self-reported questionnaires.

The results of the proposed study will provide insights with regards to the design and implementation of the main randomised controlled trial (RCT), contributing to the generation of evidence to the real-life efficacy of a mobile app-based intervention service model to support parents of children with ASD in the era of digital mental health. As the impact of mental well-being of parents extends beyond the parents themselves, effective management of the elevated level of parental stress in ASD families is beneficial to the family functioning and long-term development of the child. The solid evidence from the main trial can also inform clinicians and service-users in choosing the evidence-based intervention suitable to their context, among the range of commercially available products with claimed efficacy.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
40 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Randomised wait-list controlled trialRandomised wait-list controlled trial
Masking:
None (Open Label)
Primary Purpose:
Supportive Care
Official Title:
Pilot Testing of a Mobile Phone App-based Intervention for Supporting and Empowering Parents of Children With Autism Spectrum Disorder (ASD): a Mixed-method Study of Feasibility, Acceptability, and Preliminary Efficacy
Anticipated Study Start Date :
Aug 1, 2023
Anticipated Primary Completion Date :
Feb 1, 2024
Anticipated Study Completion Date :
Feb 1, 2024

Arms and Interventions

Arm Intervention/Treatment
Experimental: TRIP App

Both groups will be assessed at baseline on the outcome measurements, after which the immediate intervention group will begin the 6-week intervention

Other: TRIP
TRIP is a mobile app-based intervention for supporting and empowering parents of children with autism spectrum disorder (ASD), comprises of a 6-week structured training on mindfulness and educational modules on ASD parenting skills.

No Intervention: Waitlist control

Both groups will be assessed at baseline on the outcome measurements, after which the the waitlist control group will receive usual care in the following six weeks. Afterwards, the waitlist control group will complete outcome assessment once again, before receiving the 6-week intervention

Outcome Measures

Primary Outcome Measures

  1. Enrolment [Immediately post-intervention]

    Response rates during recruitment

  2. Retention (Intervention) [Immediately post-intervention]

    Dropout rates from pre-intervention to immediately post-intervention

  3. Retention (Follow-up) [2 months post-intervention]

    Dropout rates from pre-intervention to 2-month post intervention

  4. Platform used [Immediately post-intervention]

    Platform on which the app is accessed from, Apple's iPhone operating system (iOS) or Android, will be recorded

  5. Days of week of use [Immediately post-intervention]

    Whether the app is used on weekdays or weekends will be recorded

  6. Time of day of use [Immediately post-intervention]

    Time of day of use (in 4-hour blocks) will be recorded

  7. Number of app usage days [Immediately post-intervention]

    Number of days with logins within the 6-week intervention period

  8. Average duration of app usage [Immediately post-intervention]

    Time spent in app per login within the 6-week intervention period

  9. Number of unique components completed [Immediately post-intervention]

    Number of unique components completed within the 6-week intervention period

  10. Number of core session completed [Immediately post-intervention]

    Number of core session completed within the 6-week intervention period

  11. Number of optional session completed [Immediately post-intervention]

    Number of optional session completed within the 6-week intervention period

  12. App usability [Immediately post-intervention]

    Measured by the 10-item System Usability Scale (SUS; Brooke, 1996) for assessing the usability of products and apps. SUS scores have a range of 0 to 100, with a higher score means greater app usability.

  13. App quality [Immediately post-intervention]

    Measured by the 20-item Mobile Application Rating Scale - User Version (uMARS; Stoyanov et al., 2016) that measures engagement, functionality, aesthetics, information quality of mobile health apps. Scores range from 1 to 5, with a higher score indicating higher app quality.

Secondary Outcome Measures

  1. Parental anxiety [Pre-intervention]

    Measured by the 7-item Generalised Anxiety Disorder scale (GAD-7; Spitzer et al., 2006) for anxiety symptoms. GAD-7 scores range from 0 to 21, higher scores indicating greater levels of anxiety symptoms.

  2. Parental anxiety [Immediately post-intervention]

    Measured by the 7-item Generalised Anxiety Disorder scale (GAD-7; Spitzer et al., 2006) for anxiety symptoms. GAD-7 scores range from 0 to 21, higher scores indicating greater levels of anxiety symptoms.

  3. Parental anxiety [2-months post-intervention]

    Measured by the 7-item Generalised Anxiety Disorder scale (GAD-7; Spitzer et al., 2006) for anxiety symptoms. GAD-7 scores range from 0 to 21, higher scores indicating greater levels of anxiety symptoms.

  4. Parental depression [Pre-intervention]

    Measured by the 9-item Patient Health Questionnaire (PHQ-9; Kroenke et al., 2001) for depressive symptoms. PHQ-9 scores range from 0 to 27, higher scores indicating greater levels of depressive symptoms.

  5. Parental depression [Immediately post-intervention]

    Measured by the 9-item Patient Health Questionnaire (PHQ-9; Kroenke et al., 2001) for depressive symptoms. PHQ-9 scores range from 0 to 27, higher scores indicating greater levels of depressive symptoms.

  6. Parental depression [2-months post-intervention]

    Measured by the 9-item Patient Health Questionnaire (PHQ-9; Kroenke et al., 2001) for depressive symptoms. PHQ-9 scores range from 0 to 27, higher scores indicating greater levels of depressive symptoms.

  7. Parenting stress [Pre-intervention]

    Measured by the 36-item Parenting Stress Index-Short Form (PSI-SF), considering three domains of parenting distress, difficult child, and parent-child dysfunctional interaction. Scores range from 36 to 180, with higher scores indicating greater levels of stress.

  8. Parenting stress [Immediately post-intervention]

    Measured by the 36-item Parenting Stress Index-Short Form (PSI-SF), considering three domains of parenting distress, difficult child, and parent-child dysfunctional interaction. Scores range from 36 to 180, with higher scores indicating greater levels of stress.

  9. Parenting stress [2-months post-intervention]

    Measured by the 36-item Parenting Stress Index-Short Form (PSI-SF), considering three domains of parenting distress, difficult child, and parent-child dysfunctional interaction. Scores range from 36 to 180, with higher scores indicating greater levels of stress.

  10. Parenting competence [Pre-intervention]

    Measured by the 17-item Parenting Sense of Competence scale (PSOC; Gibaud-Wallston & Wandersman, 1978). Scores ranges between 17 to 102, with higher scores indicating a higher parenting sense of competency.

  11. Parenting competence [Immediately post-intervention]

    Measured by the 17-item Parenting Sense of Competence scale (PSOC; Gibaud-Wallston & Wandersman, 1978). Scores ranges between 17 to 102, with higher scores indicating a higher parenting sense of competency.

  12. Parenting competence [2-months post-intervention]

    Measured by the 17-item Parenting Sense of Competence scale (PSOC; Gibaud-Wallston & Wandersman; 1978). Scores ranges between 17 to 102, with higher scores indicating a higher parenting sense of competency.

  13. Parenting efficacy [Pre-intervention]

    Measured by the 6-item Parenting Efficacy subscale of the Parenting Self-Agency Measure (Dumka et al., 1996). Scores ranges between 6-42, with higher scores indicating higher levels of parenting efficacy.

  14. Parenting efficacy [Immediately post-intervention]

    Measured by the 6-item Parenting Efficacy subscale of the Parenting Self-Agency Measure (Dumka et al., 1996). Scores ranges between 6-42, with higher scores indicating higher levels of parenting efficacy.

  15. Parenting efficacy [2-months post-intervention]

    Measured by the 6-item Parenting Efficacy subscale of the Parenting Self-Agency Measure (Dumka et al., 1996). Scores ranges between 6-42, with higher scores indicating higher levels of parenting efficacy.

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Chinese parents living in Hong Kong

  • Parents caring for ASD children, diagnosed by clinicians according to the criteria of Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) criteria and aged ≤12

  • Recruited from the Child and Adolescent Psychiatric clinic at the Alice Ho Miu Ling Nethersole Hospital, a regional hospital providing the sole public child and adolescent psychiatric service in the New-Territory East Cluster of the Hospital Authority in Hong Kong

  • Able to read and understand Cantonese

  • Have access to an internet-enabled mobile phone with a valid phone number for the duration of the pilot trial

Exclusion Criteria:
  • Parents who are not the main carer of their ASD children

  • Currently receiving psychological interventions

  • Undergoing mindfulness training will be excluded

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Chinese University of Hong Kong

Investigators

  • Principal Investigator: Oscar Wong, MBChB, Chinese University of Hong Kong

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Wong Wing Ho, Assistant Professor (Clinical), Chinese University of Hong Kong
ClinicalTrials.gov Identifier:
NCT05927207
Other Study ID Numbers:
  • 2022.586
  • 10210356
First Posted:
Jul 3, 2023
Last Update Posted:
Jul 3, 2023
Last Verified:
Jun 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Wong Wing Ho, Assistant Professor (Clinical), Chinese University of Hong Kong
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 3, 2023